Seasonal Affective Disorder: The Evidence-Based Supplement Protocol

6 min read ·

Seasonal affective disorder (SAD) is recurrent winter-pattern major depressive episodes. Bright light therapy (10,000 lux for 30 minutes morning) is the foundational intervention with the strongest evidence — comparable in effect size to SSRIs for the seasonal pattern. Supplements have an adjunctive role.

Vitamin D — Repletion to 30+ ng/mL

Vitamin D status correlates with mood in SAD cohorts and many patients are deficient by midwinter. Repletion improves mood in deficient SAD patients but does not consistently outperform placebo in already-replete adults. Test and treat. See vitamin D piece.

Light Therapy — The Gold Standard

Not a supplement but the highest-evidence intervention. 10,000 lux full-spectrum light box for 20–30 minutes within 1 hour of waking, daily from autumn through spring. Effect size comparable to SSRIs. Mention here because any supplement protocol for SAD that omits light therapy is fundamentally incomplete.

EPA-Dominant Omega-3, 1–2 g EPA Daily

Omega-3 has positive evidence in depressive disorders broadly. SAD-specific trials are smaller but consistent with the broader signal. See omega-3 depression piece.

Saffron, 30 mg Daily

Saffron has antidepressant evidence in non-seasonal MDD; SAD-specific data is more limited. Reasonable adjunct in mild-moderate seasonal symptoms. See saffron piece.

Melatonin — Phase-Shifting, Not Mood

Low-dose melatonin (0.3 mg afternoon) has been studied for phase-shifting circadian timing in SAD. Not a mood intervention per se but addresses one mechanistic component. See melatonin dosing piece.

What NOT to Take

Avoid St. John's Wort + SSRIs simultaneously — serotonin syndrome risk. Skip "winter blues formula" megaproducts with subclinical doses. Avoid 5-HTP if on any serotonergic medication. Don't replace SSRI or light therapy with supplements in moderate-severe SAD.

How to Run the Protocol

Bright light therapy 10,000 lux × 30 min morning, daily Oct–April. Vitamin D to repletion. Omega-3 1.5 g EPA daily. Outdoor time, even on overcast days (outdoor "cloudy day" light still exceeds indoor by 10×). If symptoms remain moderate-severe, SSRI (bupropion XL has the only FDA SAD-specific indication) or psychiatry referral. See SAD condition page.

Sources

  1. Lam RW, Levitt AJ, Levitan RD, et al. "Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder." JAMA Psychiatry, 2016;73(1):56-63. PMID: 26580307. DOI: 10.1001/jamapsychiatry.2015.2235.
  2. Nussbaumer-Streit B, Forneris CA, Morgan LC, et al. "Light therapy for preventing seasonal affective disorder." Cochrane Database Syst Rev, 2019;3:CD011269. PMID: 30883673. DOI: 10.1002/14651858.CD011269.pub3.
  3. Stewart AE, Roecklein KA, Tanner S, Kimlin MG. "Possible contributions of skin pigmentation and vitamin D in a polyfactorial model of seasonal affective disorder." Medical Hypotheses, 2014;83(5):517-525. PMID: 25270233. DOI: 10.1016/j.mehy.2014.09.010.
  4. Mocking RJT, Harmsen I, Assies J, Koeter MWJ, Ruhé HG, Schene AH. "Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder." Translational Psychiatry, 2016;6(3):e756. PMID: 26978738. DOI: 10.1038/tp.2016.29.
  5. Rohan KJ, Mahon JN, Evans M, et al. "Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder." American Journal of Psychiatry, 2015;172(9):862-869. PMID: 25859764. DOI: 10.1176/appi.ajp.2015.14101293.